Task: Answer the multiple-choice question.
Question: Which compound exhibits a 0.304% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CCN1C(=O)C(=O)N(CC(=O)N(C)CC(=O)Nc2ccccc2Cl)C1=O
[b] CN1C(=O)N(C)c2ccc(Br)c3cccc1c23
[c] COCC(=O)Nc1nc(-c2ccc([N+](=O)[O-])cc2)cs1
[d] Cn1c(=O)oc2cc(S(=O)(=O)NCc3cccnc3)ccc21
[e] Cc1cccc(C(=O)NCC(=O)NCC(c2cccs2)N2CCOCC2)c1
Answer: e. Cc1cccc(C(=O)NCC(=O)NCC(c2cccs2)N2CCOCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(C(=O)NCC(=O)NCC(c2cccs2)N2CCOCC2)c1
Cc1cccc(C(=O)NCC(=O)NCC(c2cccs2)N2CCOCC2)c1
3-methyl-N-[2-[(2-morpholin-4-yl-2-thiophen-2-ylethyl)amino]-2-oxoethyl]benzamide